Standout Papers
Citation Impact
Citing Papers
Prospective identification of tumorigenic breast cancer cells
2003 Standout
Role of Genotype in the Cycle of Violence in Maltreated Children
2002 StandoutScience
Serotonin Transporter Genetic Variation and the Response of the Human Amygdala
2002 StandoutScience
Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway
2003
Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy
2010 StandoutNobel
Magnetic Resonance Imaging in Parkinsonism
1992
Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study
1994
Maldistribution of Interstitial Neurons in Prefrontal White Matter of the Brains of Schizophrenic Patients
1996
Antecedents of Predominantly Negativeand Predominantly Positive-Symptom Schizophrenia in a High-Risk Population
1990
Postnatal development of D 1 dopamine receptors in the medial prefrontal cortex, striatum and nucleus accumbens of normal and neonatal 6-hydroxydopamine treated rats: a quantitative autoradiographic analysis
1991
T1ρ and T2ρ MRI in the evaluation of Parkinson’s disease
2010
Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease
1990
Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia
1991
The Ubiquitin Proteasome System in Neurodegenerative Diseases
2003 StandoutNobel
Electroresponsiveness of medial entorhinal cortex layer III neurons in vitro
1997
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
Oxytocin, vasopressin, and autism: is there a connection?
1999
Dopamine in Schizophrenia
1996
Microstructure of a spatial map in the entorhinal cortex
2005 StandoutNatureNobel
Adult Schizophrenia Following Prenatal Exposure to an Influenza Epidemic
1988
Prenatal Ethanol Effects on NGF Level, NPY and ChAT Immunoreactivity in Mouse Entorhinal Cortex
1999
Oxidative Stress Hypothesis in Alzheimer's Disease
1997 Standout
Apomorphine stimulation of vasopressin- and oxytocin-neurophysins. Evidence for increased oxytocinergic and decreased vasopressinergic function in schizophrenics
1992
Limbic pathology in schizophrenia: The entorhinal region—a morphometric study
1988
Evidence for biochemical heterogeneity in schizophrenia: a multivariate study of monoaminergic indices in human post-mortal brain tissue
1994 StandoutNobel
Organization of the human serotonin transporter gene
1994
Brain iron and ferritin in Parkinson's and Alzheimer's diseases
1990
Beyond the Dopamine Hypothesis
1989
Abnormalities of the Left Temporal Lobe and Thought Disorder in Schizophrenia
1992 Standout
D2 Dopamine Receptors in Neuroleptic-Naive Schizophrenic Patients
1990
Schizophrenia as an Anomaly of Development of Cerebral Asymmetry
1989 Standout
Decreased Ferritin Levels in Brain in Parkinson's Disease
1990
Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains
1989
Primary structure of the serotonin transporter in unipolar depression and bipolar disorder
1995
The Expression of Key Oxidative Stress-Handling Genes in Different Brain Regions in Alzheimer's Disease
1998
Amyloid‐β‐induced toxicity of primary neurons is dependent upon differentiation‐associated increases in tau and cyclin‐dependent kinase 5 expression
2003
Application of automated MRI volumetric measurement techniques to the ventricular system in schizophrenics and normal controls
1991
Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems
1990
Cerebrospinal fluid oxytocin concentration in schizophrenic patients does not differ from control subjects and is not changed by neuroleptic medication
1994
Cerebrospinal fluid ferritin levels of patients with Parkinson's disease, Alzheimer's disease, and multiple system atrophy
1994
Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: Potential relevance to schizophrenia?
1995
The adolescent brain and age-related behavioral manifestations
2000 Standout
Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk
2008
Isolation of a cDNA encoding the human brain serotonin transporter
1993
cDNAs with long CAG trinucleotide repeats from human brain
1997
PSYCHONEUROENDOCRINOLOGY OF CHILDREN AND ADOLESCENTS
1998
Functional Imaging of Neural Responses to Expectancy and Experience of Monetary Gains and Losses
2001 StandoutNobel
Altered Distribution of Nicotinamide-Adenine Dinucleotide Phosphate—Diaphorase Cells in Frontal Lobe of Schizophrenics Implies Disturbances of Cortical Development
1993
Neurochemical Sensitization in the Pathophysiology of Schizophrenia: Deficits and Dysfunction in Neuronal Regulation and Plasticity
1997
A Quantitative Investigation of Hippocampal Pyramidal Cell Size, Shape, and Variability of Orientation in Schizophrenia
1989
C. elegans Locomotory Rate Is Modulated by the Environment through a Dopaminergic Pathway and by Experience through a Serotonergic Pathway
2000 StandoutNobel
Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease
1994
Substantia innominata: a notion which impedes clinical–anatomical correlations in neuropsychiatric disorders
1997
Amyloid β-protein toxicity and oxidative stress in Alzheimer's disease
1997
Schizophrenia: the cellular biology of a functional psychosis
1990
The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia
1999
Nucleokinesis in Neuronal Migration
2005
Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study
1992
Studies Toward the Subcortical Pathogenesis of Schizophrenia
1987
Frontal Cortical and Left Temporal Glutamatergic Dysfunction in Schizophrenia
1989
Impairments on Neuropsychologic Tests of Temporohippocampal and Frontohippocampal Functions and Word Fluency in Remitting Schizophrenia and Affective Disorders
1988
The neurodevelopmental model of schizophrenia: update 2005
2005
Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental lewy body disease
1992
Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters
2005 StandoutNature
Oxidative stress in Parkinson's disease
2003 Standout
Protective and Damaging Effects of Stress Mediators
1998 Standout
Increased monoamine oxidase b activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography
1994
Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein
2002
Myelination of Cortical-hippocampal Relays During Late Adolescence
1989
Quantitative Neuroanatomy in Schizophrenia
1988
Serotonin receptor binding in a colony model of chronic social stress
1995
Rethinking schizophrenia
2010 StandoutNature
“Perestroika” in the basal forebrain: Opening the border between neurology and psychiatry
1991
Twin Studies of Psychiatric Illness
2001
Oxidative stress as a cause of Parkinson's disease
1991
Subgenual prefrontal cortex abnormalities in mood disorders
1997 StandoutNature
Peripheral iron metabolism in patients with Parkinson's disease
1994
Association analysis of schizophrenia on 18 genes involved in neuronal migration: MDGA1 as a new susceptibility gene
2008
A Novel Multiple PDZ Domain-containing Molecule Interacting withN-Methyl-d-aspartateReceptors and Neuronal Cell Adhesion Proteins
1998 StandoutNobel
Iron and Aluminum Increase in the Substantia Nigra of Patients with Parkinson's Disease: An X‐Ray Microanalysis
1991
The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it
1992
Innate immunity: the missing link in neuroprotection and neurodegeneration?
2002
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases
2006 StandoutNature
Perinatal Complications and Reduced Size of Brain Limbic Structures in Familial Schizophrenia
1988
Schizophrenia and the brain: a prospective clinico-neuropathological study
1990
Genomic Rearrangements and Gene Copy-Number Alterations as a Cause of Nervous System Disorders
2006
The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function
2003 Standout
Anatomical Abnormalities in the Brains of Monozygotic Twins Discordant for Schizophrenia
1990
Childhood Cognitive Functioning in Schizophrenia Patients and Their Unaffected Siblings: A Prospective Cohort Study
2000
Some Cytoarchitectural Abnormalities of the Entorhinal Cortex in Schizophrenia
1991
A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity
2000
Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders
2002
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implications
1997 StandoutNobel
Cerebral organoids model human brain development and microcephaly
2013 StandoutNature
Association of a regulatory polymorphism in the promoter region of the monoamine oxidase A gene with antisocial alcoholism
1999
Schizophrenia and the Hippocampus: The Embryological Hypothesis Extended
1987
BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain
2005 StandoutNature
Hippocampal Pathologic Findings in Schizophrenia
1989
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Oxygen free radicals and Parkinson's disease
1991
Medial and superior temporal gyral volumes and cerebral asymmetry in schizophrenia versus bipolar disorder
1997
Chronic high dose L-DOPA alone or in combination with the COMT inhibitor entacapone does not increase oxidative damage or impair the function of the nigro-striatal pathway in normal cynomologus monkeys
2002
The neuropathology of primary mood disorder
2002
Event-related potentials in schizophrenia: their biological and clinical correlates and new model of schizophrenic pathophysiology
1991
Homo- and Heterodimerization of Synapsins
1999 StandoutNobel
The molecular neurobiology of depression
2008 StandoutNature
Iron‐sulfur enzyme mediated mitochondrial superoxide toxicity in experimental Parkinson's disease
2004
Hypoxia-inducible Factor Prolyl 4-Hydroxylase Inhibition
2005
A Meta-analysis of the Efficacy of Second-Generation Antipsychotics
2003
Increased temporal lobe glucose use in chronic schizophrenic patients
1989
Elevated Cerebrospinal Fluid Levels of Oxytocin in Obsessive-compulsive Disorder
1994
Dopa and dopamine cause cultured neuronal death in the presence of iron
1991
Pharmacogenetics and the serotonin system: initial studies and future directions
2000
Monoamine Oxidase in Neuropsychiatry and Behavior
1999
MDGAs interact selectively with neuroligin-2 but not other neuroligins to regulate inhibitory synapse development
2012 StandoutNobel
Neonatal Insult to the Hippocampal Region and Schizophrenia: A Review and a Putative Animal Model
1996
Synthesis of Serotonin by a Second Tryptophan Hydroxylase Isoform
2003 StandoutScience
Oxidants, antioxidants, and the degenerative diseases of aging.
1993 Standout
Reversal of asymmetry of the planum temporale in schizophrenia
1995
Basal Ganglia and Limbic System Pathology in Schizophrenia
1985
A catechol- O -methyltransferase that is essential for auditory function in mice and humans
2008 StandoutNobel
Neurogenetic Adaptive Mechanisms in Alcoholism
1987 StandoutScience
Is there a schizophrenic language?
1982
Striatal D2 dopaminergic receptors assessed with positron emission tomography and [76Br]bromospiperone in untreated schizophrenic patients
1990
Depression Following Myocardial Infarction
1993 Standout
Maternal influenza, obstetric complications, and schizophrenia
1995
The Computational Anatomy of Psychosis
2013
A third member of the synapsin gene family
1998
Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11.
1995
Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia
1990
Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling
2005
Human fear conditioning is related to dopaminergic and serotonergic biological markers.
2001
The cell-adhesion G protein-coupled receptor BAI3 is a high-affinity receptor for C1q-like proteins
2011 StandoutNobel
Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging
1996
Hippocampus-independent phase precession in entorhinal grid cells
2008 StandoutNatureNobel
A General Mechanism for Network-Dosage Compensation in Gene Circuits
2010 StandoutScienceNobel
Morphological characterization of rat entorhinal neurons in vivo: soma-dendritic structure and axonal domains
1991
Synapsins regulate use-dependent synaptic plasticity in the calyx of Held by a Ca 2+ /calmodulin-dependent pathway
2006 StandoutNobel
Spermidine in health and disease
2018 StandoutScience
Neurotransmitter Transporters in the Central Nervous System
1999
Luminescent Functional Metal–Organic Frameworks
2011 Standout
Pavlovian conditioning–induced hallucinations result from overweighting of perceptual priors
2017 StandoutScience
Postmortem studies in schizophrenia
2000
Amine metabolites, neuroendocrine findings, and personality dimensions as correlates of suicidal behavior
1983
Asymmetry of Chimpanzee Planum Temporale: Humanlike Pattern of Wernicke's Brain Language Area Homolog
1998 StandoutScience
Functional and Anatomical Aspects of Prefrontal Pathology in Schizophrenia
1997
MRI of the human brain at 130 microtesla
2013 StandoutNobel
A faulty negative feedback control underlies the schizophrenic syndrome?
1991 StandoutNobel
Normal Mitochondrial Genome in Brain from Patients with Parkinson's Disease and Complex I Defect
1990
The diencephalon in schizophrenia: Evidence for reduced thickness of the periventricular grey matter
1984
The neurodevelopmental basis of sex differences in schizophrenia
1991
The Oxytocin Receptor System: Structure, Function, and Regulation
2001 Standout
Synergistic effect of HIF-1α gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia
2009 StandoutNobel
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
2007 StandoutScience
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
1993 StandoutScience
Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease
1993
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
1987 Standout
Nitric oxide prevents axonal degeneration by inducing HIF-1–dependent expression of erythropoietin
2011 StandoutNobel
Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region
1996 StandoutScience
Schizophrenia as a Disorder of Neurodevelopment
2002
Heritability estimates for psychotic disorders: the Maudsley twin psychosis series.
1999
Copper, iron, and zinc ions homeostasis and their role in neurodegenerative disorders (metal uptake, transport, distribution and regulation)
2009
Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models.
2000 Standout
Sensation seeking: A comparative approach to a human trait
1984
Dopamine Metabolism in the Cerebrospinal Fluid of Drug-Free Schizophrenic Patients With and Without Cortical Atrophy
1986
Works of H. Beckmann being referenced
Periodic catatonia: A schizophrenic subtype with major gene effect and anticipation
1995
Splitting Schizophrenia: Periodic Catatonia–Susceptibility Locus on Chromosome 15q15
2000
The human striatum in schizophrenia. II. Increased number of striatal neurons in schizophrenics
1997
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
1988
A Double-Blind Comparative Multicentre Study of Controlled-Release Remoxipride, Immediate-Release Remoxipride and Haloperidol in Schizophrenia
1991
Prenatal disturbances of nerve cell migration in the entorhinal region: a common vulnerability factor in functional psychoses?
1991
Cortex, white matter, and basal ganglia in schizophrenia: A volumetric postmortem study
1991
Demonstration of monoamine oxidase-A and -B in the human brainstem by a histochemical technique
1989
A double‐blind multicentre study comparing remoxipride, two and three times daily, with haloperidol in schizophrenia
1990
Systematic search for variation in the human norepinephrine transporter gene: Identification of five naturally occurring missense mutations and study of association with major psychiatric disorders
1996
(3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients
1989
Zur Serotonin-Hypothese der Depression*
1990 Standout
Decreased Catalase Activity but Unchanged Superoxide Dismutase Activity in Brains of Patients with Dementia of Alzheimer Type
1995
Cortical layer I changes in schizophrenia: a marker for impaired brain development?
1997
Excess of High Activity Monoamine Oxidase A Gene Promoter Alleles in Female Patients with Panic Disorder
1999
3H-spiperone binding sites in post-mortem brains from schizophrenic patients: Relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms
1989
Growth Hormone (GH) Response to GH-Releasing Hormone in Depression
1987
Different Genetic Background of Schizophrenia Spectrum Psychoses: A Twin Study
1998
Gross and Histological Criteria for Developmental Disorders in Brains of Schizophrenics
1989
HLA antigens and schizophrenia: A pool of two studies
1981
The HLA system and schizophrenia
1980
Vasopressin-oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls
1985
Gene-Environment Interaction in Schizophrenia: Season-of-Birth Effect Reveals -Etiologically Different Subgroups
1996
Dopamine and noradrenalin in the cerebrospinal fluid of schizophrenic patients
1983
Platelet MAO activity and personality characteristics
1981
Die kraniale Computertomographie in der Schizophrenieforschung
1981
Multidimensional analysis of the concentrations of 17 substances in the CSF of schizophrenics and controls
1985
The effect of neuroleptic treatment and of high dosage diazepam therapy onβ-endorphin immunoreactivity in plasma of schizophrenic patients
1984
[Neurotransporters : new aspects of the mechanism of action of psychotropic drugs].
1993
The role of maternal infectious diseases during pregnancy in the etiology of schizophrenia in offspring
1992
Prenatal developmental disturbances in the limbic allocortex in schizophrenics
1986